141 related articles for article (PubMed ID: 37656097)
1. Effect of Carvedilol vs Metoprolol on Atrial and Ventricular Arrhythmias Among Implantable Cardioverter-Defibrillator Recipients.
Diamond A; Goldenberg I; Younis A; Goldenberg I; Sampath R; Kutyifa V; Chen AY; McNitt S; Polonsky B; Steinberg JS; Zareba W; Aktaş MK
JACC Clin Electrophysiol; 2023 Oct; 9(10):2122-2131. PubMed ID: 37656097
[TBL] [Abstract][Full Text] [Related]
2. Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy).
Ruwald MH; Abu-Zeitone A; Jons C; Ruwald AC; McNitt S; Kutyifa V; Zareba W; Moss AJ
J Am Coll Cardiol; 2013 Oct; 62(15):1343-50. PubMed ID: 23770172
[TBL] [Abstract][Full Text] [Related]
3. Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study.
Ruwald AC; Gislason GH; Vinther M; Johansen JB; Nielsen JC; Philbert BT; Torp-Pedersen C; Riahi S; Jøns C
Europace; 2018 Sep; 20(FI2):f217-f224. PubMed ID: 29684191
[TBL] [Abstract][Full Text] [Related]
4. A comparison of anti-arrhythmic efficacy of carvedilol vs metoprolol succinate in patients with implantable cardioverter-defibrillators.
Ayan M; Habash F; Alqam B; Gheith Z; Cross M; Vallurupalli S; Paydak H
Clin Cardiol; 2019 Feb; 42(2):299-304. PubMed ID: 30592068
[TBL] [Abstract][Full Text] [Related]
5. QRS Morphology and the Risk of Ventricular Tachyarrhythmia in Cardiac Resynchronization Therapy Recipients.
Goldenberg I; Aktas MK; Zareba W; Tsu-Chau Huang D; Rosero SZ; Younis A; McNitt S; Stockburger M; Steinberg JS; Buttar RS; Merkely B; Kutyifa V
JACC Clin Electrophysiol; 2024 Jan; 10(1):16-26. PubMed ID: 38032575
[TBL] [Abstract][Full Text] [Related]
6. Age and the Risk of Ventricular Tachyarrhythmia in Patients With an Implantable Cardioverter-Defibrillator.
Aktaş MK; Younis A; Saxena S; Diamond A; Ojo A; Kutyifa V; Steiner H; Steinberg JS; Zareba W; McNitt S; Polonsky B; Rosero SZ; Huang DT; Goldenberg I
JACC Clin Electrophysiol; 2023 Jul; 9(7 Pt 1):979-988. PubMed ID: 36752470
[TBL] [Abstract][Full Text] [Related]
7. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).
Ruwald MH; Ruwald AC; Jons C; Alexis J; McNitt S; Zareba W; Moss AJ
J Am Coll Cardiol; 2013 Apr; 61(14):1518-26. PubMed ID: 23500269
[TBL] [Abstract][Full Text] [Related]
8. Survival After Implantable Cardioverter-Defibrillator Shocks.
Aktaş MK; Younis A; Zareba W; Kutyifa V; Klein H; Daubert JP; Estes M; McNitt S; Polonsky B; Goldenberg I
J Am Coll Cardiol; 2021 May; 77(20):2453-2462. PubMed ID: 34016257
[TBL] [Abstract][Full Text] [Related]
9. Predictors and outcomes of atrial tachyarrhythmia among patients with implantable defibrillators.
Younis A; Heist EK; McNitt S; Aktas MK; Rosero S; Goldenberg I; Kutyifa V
Heart Rhythm; 2020 Apr; 17(4):553-559. PubMed ID: 31765809
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Importance of Defibrillator-Appropriate Shocks and Antitachycardia Pacing in Patients With Mild Heart Failure.
Biton Y; Daimee UA; Baman JR; Kutyifa V; McNitt S; Polonsky B; Zareba W; Goldenberg I
J Am Heart Assoc; 2019 Mar; 8(6):e010346. PubMed ID: 30857452
[TBL] [Abstract][Full Text] [Related]
11. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
[TBL] [Abstract][Full Text] [Related]
12. The use of guideline recommended beta-blocker therapy in primary prevention implantable cardioverter defibrillator patients: insight from Danish nationwide registers.
Ruwald AC; Gislason GH; Vinther M; Johansen JB; Nielsen JC; Petersen HH; Torp-Pedersen C; Riahi S; Jøns C
Europace; 2018 Feb; 20(2):301-307. PubMed ID: 28339659
[TBL] [Abstract][Full Text] [Related]
13. Propranolol Versus Metoprolol for Treatment of Electrical Storm in Patients With Implantable Cardioverter-Defibrillator.
Chatzidou S; Kontogiannis C; Tsilimigras DI; Georgiopoulos G; Kosmopoulos M; Papadopoulou E; Vasilopoulos G; Rokas S
J Am Coll Cardiol; 2018 May; 71(17):1897-1906. PubMed ID: 29699616
[TBL] [Abstract][Full Text] [Related]
14. Reassessing the role of antitachycardia pacing in fast ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Results from MADIT-RIT.
Schuger C; Daubert JP; Zareba W; Rosero S; Yong P; McNitt S; Kutyifa V
Heart Rhythm; 2021 Mar; 18(3):399-403. PubMed ID: 33232811
[TBL] [Abstract][Full Text] [Related]
15. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
Bollmann A; Husser D; Cannom DS
Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
[TBL] [Abstract][Full Text] [Related]
18. Novel ICD Programming and Inappropriate ICD Therapy in CRT-D Versus ICD Patients: A MADIT-RIT Sub-Study.
Kutyifa V; Daubert JP; Schuger C; Goldenberg I; Klein H; Aktas MK; McNitt S; Stockburger M; Merkely B; Zareba W; Moss AJ
Circ Arrhythm Electrophysiol; 2016 Jan; 9(1):e001965. PubMed ID: 26743237
[TBL] [Abstract][Full Text] [Related]
19. Digitalis Therapy and Risk of Recurrent Ventricular Tachyarrhythmias and ICD Therapies in Atrial Fibrillation and Heart Failure.
Schupp T; Behnes M; Weiss C; Nienaber C; Reiser L; Bollow A; Taton G; Reichelt T; Ellguth D; Engelke N; Rusnak J; Weidner K; Akin M; Mashayekhi K; Borggrefe M; Akin I
Cardiology; 2019; 142(3):129-140. PubMed ID: 31189160
[TBL] [Abstract][Full Text] [Related]
20. Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II).
Brodine WN; Tung RT; Lee JK; Hockstad ES; Moss AJ; Zareba W; Hall WJ; Andrews M; McNitt S; Daubert JP;
Am J Cardiol; 2005 Sep; 96(5):691-5. PubMed ID: 16125497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]